Results 271 to 280 of about 106,421 (289)

Atypical Pediatric‐Onset Behçet's Disease Presenting With Superior Vena Cava Thrombosis in an Adolescent Male: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Behçet's disease is a chronic, relapsing multisystem vasculitis known for its highly variable clinical spectrum. We report the case of an 18‐year‐old male who presented with progressive headache and facial swelling. Imaging revealed extensive thrombosis involving the dural venous sinuses, superior vena cava, and left brachiocephalic vein ...
Ubaid Ullah   +8 more
wiley   +1 more source

Remimazolam‐Induced Paradoxical Reaction in a Bipolar Patient: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT This first reported case of remimazolam‐induced paradoxical reaction (PR) in a bipolar disorder patient highlights that GABAergic dysfunction may heighten PR risk. Flumazenil effectively reversed the symptoms, underscoring the need for caution and preparedness when using benzodiazepines in this vulnerable population.
Zhifu Zhao, Li Liu, Xianjie Zhang
wiley   +1 more source

Small Bowel Obstruction due to Meckel's Diverticulum: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Meckel's diverticulum should be considered in cases of unexplained small bowel obstruction, especially in pediatric and adolescent patients. Early recognition and timely surgical intervention can prevent complications and lead to favorable outcomes.
Mansab Ali   +10 more
wiley   +1 more source

Biopsychosocial Insights on Adolescents With Chronic Urticaria: The Role of Eosinophils and Stress Coping Strategies

open access: yesClinical and Translational Allergy, Volume 15, Issue 12, December 2025.
ABSTRACT Background Chronic spontaneous urticaria (CSU) often lacks a clear etiology. While autoimmune and allergic factors can trigger it, stress and life events also play significant roles. As in other psychosomatic disorders, effective stress coping strategies are key to understanding and managing CSU.
Talat Sarikavak   +3 more
wiley   +1 more source

Pharmacokinetics, Tolerability, and Biomarker Profile of the Neurokinin 3 Receptor Antagonist Fezolinetant in Healthy Japanese Individuals: A 2‐Part, Randomized, Phase 1 Study

open access: yesClinical Pharmacology in Drug Development, Volume 14, Issue 12, Page 934-950, December 2025.
Abstract This 2‐part, randomized, placebo‐controlled, double‐blind, Phase 1 study analyzed the pharmacokinetics, safety, and biomarker profile of fezolinetant in healthy Japanese individuals. Part 1: male participants received single doses of placebo or fezolinetant 15 or 60 mg.
Akira Koibuchi   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy